Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
lipidsænkende middel i form af fibrat |
Is a |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Anion exchange resin |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Bile acid sequestrant antilipemic agent (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
HMG-CoA reductase inhibitor |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Lipid-lowering drug adverse reaction |
Causative agent |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
1 |
Dextrothyroxine sodium adverse reaction |
Causative agent |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Acipimox adverse reaction |
Causative agent |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Fish oils adverse reaction |
Causative agent |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Omega 3-marine triglycerides adverse reaction |
Causative agent |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
allergi over for lipidsænkende lægemiddel |
Causative agent |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
allergi over for dextrothyroxinnatrium |
Causative agent |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Allergy to fish oil |
Causative agent |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Allergy to fish derived omega 3 fatty acid |
Causative agent |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Lipid-lowering drug overdose |
Causative agent |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
1 |
Probucol (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Gemfibrozil (substance) |
Is a |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Clofibrate (substance) |
Is a |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Acipimox |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
kolesterolsænkende lægemiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Adverse reaction to antilipemic and antiarteriosclerotic drugs NOS |
Causative agent |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Ezetimibe (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Policosanol (substance) |
Is a |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Dextrothyroxine sodium |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
loppefrøskaller 3,4 g/brev sukkerfrit pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
loppefrøskaller 6 g/brev sukkerfrit pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
sennes 12,4 % + loppefrø 54,2 % granulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
loppefrøskaller 3,5 g brev sukkerfrit granulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
marine omega-3-triglycerider |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Fish derived omega 3 fatty acid 1 g oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
fiskeolie, flydende koncentrat oral væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Product containing fish derived omega 3 fatty acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
loppefrøskaller pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
loppefrøskalsgranulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Product containing ispaghula husk (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Product containing docosahexaenoic acid and eicosapentaenoic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
omega-3-syreethylester 1 g blød gelatinekapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
lipidsænkende middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Product containing psyllium and senna (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Ispaghula husk [gastro-intestinal bulk laxative] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Ispaghula husk 56% powder 6.4g |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Ispaghula husk [lipid lowering use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
loppefrøskaller 3,5 g/brev sukkerfrit pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Product containing ispaghula husk and mebeverine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
loppefrøskaller 3,5 g glutenfrit, sukkerfrit brusesgranulat i brev |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Peroxisome proliferator-activated alpha receptor agonist |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
allergi over for lipidsænkende lægemiddel |
Causative agent |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
1 |
Tiadenol (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Product containing 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Evolocumab (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Mipomersen (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Lomitapide (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Benfluorex (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Lomitapide mesilate (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Mipomersen sodium (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Dextrothyroxine (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Levocarnitine |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Loteprednol (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Bempedoic acid (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Loteprednol etabonate (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Evinacumab (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Inclisiran (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Nicofuranose (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Inclisiran sodium (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|
Eicosapentaenoic acid ethyl ester (substance) |
Is a |
True |
Antilipemic agent (substance) |
Inferred relationship |
Some |
|